Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

Igencia (Burlingame, CA) a development-stage biopharmaceutical company focused on the discovery of tumor antigens and in vivo antibody screen platforms for various oncologic indications, closed a $24M Series B financing. Participants include The Column Group, OrbiMed and 5AM Ventures.

Aragon Pharmaceuticals (San Diego, CA) a preclinical-stage stage small molecule company focused on therapeutics for the treatment of hormone-resistant cancers, with an initial focus on prostate and breast cancer, closed a $22M Series B financing. Participants include Aisling Capital, OrbiMed and The Column Group.

The ‘Looking for Some (More) of This?’ series is focused upon the tracking of newly formed venture funds who are financing biomedical innovation. Whilst many continue to pound the drum echoing the sentiment that limited partners remain sidelined, here is additional demonstration of continued new capital formation in the life science sector, courtesy of OrbiMed, […]

Adimab (Lebanon, NH) a commercial-stage yeast-based antibody discovery and optimization platform, closed a $8.2M Series D financing. Participants include Google Ventures, OrbiMed, Borealis Ventures,Polaris Venture Partners and SV Life Sciences. Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb

« Previous Page  Next Entries »

to top of page...